[Lipoatrophy after use of long acting insulin glargine analogue in a 32-year-old patient with type 1 diabetes].

Dziura, Maria; Wasikowa, Renata

[Lipoatrophy after use of long acting insulin glargine analogue in a 32-year-old patient with type 1 diabetes]. / Lipoatrofia po zastosowaniu dlugo dzialajacego analogu insuliny glarginy u 32-letniej pacjentki z cukrzyca typu 1.

Dziura, Maria; Wasikowa, Renata.

Affiliation

Dziura M; Oddzial Diabetologiczny Miedziowego Centrum Zdrowia w Lubinie. mariadziura@wp.pl

Pediatr Endocrinol Diabetes Metab ; 14(1): 61-3, 2008.

Article in Pl | MEDLINE | ID: mdl-18577350

Subject(s)

Diabetes Mellitus, Type 1/drug therapy; Hypoglycemic Agents/adverse effects; Insulin/analogs & derivatives; Lipodystrophy/chemically induced; Lipodystrophy/prevention & control; Adult; Hashimoto Disease/complications; Humans; Hypothyroidism/complications; Insulin/administration & dosage; Insulin/adverse effects; Insulin Aspart; Insulin Glargine; Insulin, Isophane; Insulin, Long-Acting/administration & dosage; Insulin, Regular, Human; Isophane Insulin, Human; Male

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Hypoglycemic Agents / Insulin / Lipodystrophy Limits: Adult / Humans / Male Language: Pl Journal: Pediatr Endocrinol Diabetes Metab Year: 2008 Document type: Article

Search on Google

XML

PubMed Links